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Towards a formalin-free hospital. Levels of
15-F2t-isoprostane and malondialdehyde to
monitor exposure to formaldehyde in nurses
from operating theatres
Valeria Bellisario,a Giulio Mengozzi,b Elena Grignani,c Massimiliano Bugiani,d
Anna Sapino,e Gianni Bussolatie and Roberto Bono*a
Purpose: nurses are exposed to formaldehyde when managing surgical samples that are to be later trans-
ferred to histopathology. We evaluated the conditions favouring the risk of exposure to this toxic reagent
and the effect of measures to prevent it. Methods: we conducted a cross-sectional study where 94
female workers were enrolled as being potentially exposed to formaldehyde. From each nurse were col-
lected: (1) personal air-formaldehyde by a personal dosimeter (8 hours), (2) a standardized questionnaire,
(3) a urine sample to test 15-F2t-isoprostane, malondialdehyde, cotinine. Results: the results indicate a
marked difference related to the adoption of the under vacuum sealing procedure, as an alternative to
formaldehyde for preserving tissues. Nurses using the under vacuum sealing system in the operating
rooms are exposed to levels of formaldehyde 75% lower than those who do not use that system. Oxidative
stress biomarkers (15-F2t-isoprostane, malondialdehyde) are significantly higher in nurses using form-
aldehyde (p < 0.001) and in the absence of the under vacuum sealing system (p = 0.027), in particular in
those workers who use liquid formaldehyde in the operating theatre (p = 0.012). Conclusions: analysis of
the biological biomarkers confirms a direct responsibility of air formaldehyde on the onset of oxidative
stress while the use of the under vacuum sealing technique is associated with a significant reduction of
the exposure to air-formaldehyde and redox status. Our findings can be useful to characterize the
environmental health risk in operating theatres and to plan preventive measures such as the under
vacuum sealing procedure.
Introduction
Formaldehyde (FA) is an important chemical widely used in
many working environments including hospitals.1–5 Since FA
represents a ubiquitous pollutant, breathable at variable levels
in every living and working environment, the study of the
relationship between exposure to this reagent, its biological
effect and related diseases is important, but rather complex.
On the whole, exposure to FA is associated with a wide
range of adverse health effects, from mild to severe.6,7 In par-
ticular, acute exposure to FA can cause irritation (of eyes, nose,
throat, and skin), nasal congestion, sore throat, headache,
cough, conjunctivitis, fatigue, rashes, shortness of breath,
nausea and nosebleeds.8,9 FA is also known as a human carci-
nogen and an inducer of chronic toxicity, being endowed with
genotoxic and oxidant activities.1,10–12 Among the chronic
effects of FA, an increased incidence of nasopharyngeal cancer
in definite FA-exposed workers was demonstrated by some
authors13,14 while others have shown a relationship between
FA and leukemia.15,16
Previous studies of our group already showed that FA,
breathed in appropriate concentrations, is able to induce an
oxidative imbalance.17 To overcome and counteract this oxi-
dative imbalance induced by FA, detoxifying enzymes are pro-
duced through different metabolic pathways.18,19 For example,
F2-isoprostanes (F2-IsoPs) are prostaglandin-like bioactive com-
pounds formed in vivo from the free radical-catalyzed per-
oxidation of essential fatty acids, like arachidonic acid. F2-IsoPs
are stable and reliable molecules, detectable in all human
tissues and biological fluids, including plasma, urine, the fluid
of bronchoalveolar lavage and cerebrospinal fluid. Based on
their mechanism of synthesis, four F2-IsoP regioisomers
(5-, 12-, 8-, or 15-series) may be generated, depending on which
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side of the chain the carbon atom is connected to. A F2-IsoP,
produced abundantly in vivo and extensively tested for biologi-
cal activity, is 15-F2t-IsoP (8-iso-PGF2α), where “2t” is due to the
trans position of the oriented side chain to the prostane ring.20
Recent studies stressed the usefulness of 15-F2t-IsoP to
assess the oxidant stress in humans17,21–23 and also to high-
light pathological conditions.24,25 Since F2-IsoPs can be
detected in a urine specimen in a noninvasive way, these mole-
cules have been proposed as a suitable biomarker for oxidative
stress.12,26 Another biomarker for lipid peroxidation is malon-
dialdehyde (MDA), which is generated in vivo via the per-
oxidation of polyunsaturated fatty acids and interacts with
proteins, itself being potentially atherogenic.18 Free radicals
are able to activate the lipid peroxidation process in an organ-
ism and their increase causes an overproduction of MDA,
which represents one of the final products of the peroxidation
of polyunsaturated fatty acids in the cells. MDA is commonly
known as a biomarker of oxidative stress, but is also able to
highlight the oxidative status in oncologic patients. Thus, data
of epidemiological studies on humans support the signifi-
cance of MDA as a predictor of the imbalance in the oxidative
stress status and lipid peroxidation. A recent paper by our
group27 has shown that the histological process of tissue fix-
ation in FA also implies an oxidative damage of DNA as
revealed by the formation of 3-(2-deoxy-β-D-erythro-pentafurano-
syl-pyrimido[1,2-α]purin-10(3H)-one (M1dG)). In particular,
that paper showed that the percentage of M1dG adducts
formed when the formalin-fixation procedures were adopted,
was about 4–5 fold greater as compared to frozen tissues,
which avoid the use of formaldehyde.
Interest in studies on exposure to this toxic substance was,
if possible, enhanced by a recent process leading to a formal
banning of FA in European countries in 2016, as a conse-
quence of EC Regulation no. 605/2014 of 05.06.2014 that mod-
ifies EC Regulation no. 1272/2008. In some working processes,
a complete ban might be unattainable because of the lack of
substitutes and specifically, thus, special exemptions for for-
malin use are going to be advanced. However, these requests
should go in parallel with a deeper knowledge of the risk of
exposure, while technical improvements and plans to reduce it
to safe levels should be adopted.
In healthcare, formalin is commonly used for fixing and
preserving biological specimens for pathological and histo-
logical examination or as a bactericide in embalming fluids
and medical laboratories.15 This practice is currently effected
in two alternative ways, either by pouring liquid FA (3–5 litres)
in large containers, or by using prefilled vials (containing
50–100 ml of FA). At variance with the use of FA, and with the
specific goal of reducing exposure to this reagent, since a few
years our hospital has adopted the practice of Under-Vacuum
Sealing (UVS) which involves the introduction of tissues
removed by surgeons into a special plastic bag, afterwards
placed under vacuum and chilled at +4 °C until being trans-
ferred to the pathology laboratory.
The UVS procedure has potential for introducing some
important improvements: (a) it avoids the use of FA and the
consequent human FA exposure in operating rooms, (b)
retains very well the anatomical and immunohistochemical
features of tissues while reducing DNA damage, (c) enhances
the preservation of both structure and tissue components (pro-
teins, nucleic acids), and (d) lengthens the useful time before
tissue fixation.28,29 Moreover, tissues processed with UVS are
suitable for tissue banking and cell culture.30 Since the use of
the UVS procedure in the hospitals selected for this study was
actually active only in some operating theatres, we intended to
check if the adoption of this procedure implied objective
differences in exposure to FA and variations in the related bio-
logical response. Specifically, we have assessed the intensity of
oxidative stress and correlated it to the intensity of exposure to
FA vapours.
To achieve this goal, we enrolled as volunteers a group of
healthy female nurses, partly smokers, attending different
operating theatres which adopted or not the UVS system and
made use or not of FA. Cohorts with different exposure scen-
arios have been compared with one another through the
quantification of 15-F2t-IsoP and MDA as markers of lipid per-
oxidation, in order to assess different FA exposures and the
effectiveness of different tissue preservation procedures (UVS
vs. FA). For each of the workers, exposure to tobacco smoke, a
confounder because it is an inducer of oxidative stress, was
quantified using cotinine values as a marker.
Methods
Study-subjects
Ninety-four female workers, recruited in the largest hospital of
the Piedmont region in Italy (“Città della Salute e della
Scienza” of Torino), were enrolled as subjects potentially
exposed to FA in the operating theatre. In agreement with the
standards of the institutional ethical committee on human
experimentation and with the Helsinki declaration, all subjects
were informed about the objectives of the study, and gave
written, informed consent. Nurses, operating in surgical thea-
tres, are traditionally exposed to FA because of the common
and traditional practice of immersing surgical samples, of a
size ranging between 2 and 30 cm, in this preservative liquid
(3–5 litres at a time) to be later transferred to a pathology lab.
The preservation technique whose effectiveness we want to
verify consists of introducing the specimen removed by a
surgeon into special plastic bags and then inducing the com-
plete removal of air from the plastic bags. UVS bags are then
preserved at 4 °C until their transfer to the pathology lab. The
94 subjects, according to their professional involvement and
exposition, were a posteriori grouped into 2 groups, the first
was composed of nurses working, on the day of sampling, in
surgical theatres equipped with the apparatus (Tissue SAFE,
Milestone, Bergamo, Italy) for the UVS procedure, the second
group was of nurses from theatres not engaged in this pro-
cedure and where the standard for all surgical specimens was
the immersion of samples in large containers in which liquid
FA (3–5 liters at a time) was poured.
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In both types of theatres small biopsies (core or incisional)
were immersed in vials (DiaPath, Bergamo, Italy) pre-filled
with FA (50–100 ml) and sent to the pathology laboratory.
Nurses from the first type of surgical theatres (UVS-equipped)
were occasionally also committed to the management of liquid
FA, for filling up containers for specimens/organs >30 cm in
size, but most specimens (over 95%) were processed by UVS.
On Wednesday and Thursday, for each of the 94 subjects,
were collected the following items: (1) a personal air-FA
sampling for one entire working shift (8 hours), (2) a standar-
dized questionnaire, (3) a urine sample for the quantification
of 15-F2t-IsoP, MDA, urinary cotinine and creatinine (CREA). A
specimen of urine at the end of the working shift was collected
from each volunteer and stored at −80 °C until analysis. On
the whole, the only exclusion criteria was thus not to recruit
males whereas all the females who voluntarily joined the study
were included and recruited.
Personal air-FA
FA air samples were collected for a working shift (8 hours)
using passive, personal air samplers working with a radial
symmetry (Radiello®). The sampler was clipped near the
breathing zone of the subject to quantify as accurately as poss-
ible the air exposure during a work shift. Each sampler was
equipped with a specific sorbent tube containing silica gel
coated with 2,4-dinitrophenylhydrazine – DNPH – (NIOSH
2016). The DNPH, reacting with FA, changes by derivatization
to 2,4-dinitrophenylhydrazone specific for the FA. Sub-
sequently, the tube was quantified with a HPLC Perkin-Elmer
equipped with a UV detector regulated at 360 nm.31,32
Questionnaire
On the same day of the personal air sampling, a questionnaire
(a synthesis of the most extensive “GEIRD” questionnaire,
http://www.geird.org) was administered to all subjects by one
interviewer to obtain information on individual, clinical
features and smoking habits. Thus, the following individual
and clinical information was acquired: age, sex, residence,
hobbies, therapies, smoking habits, profession (qualifications,
seniority, and job-specific work), use of FA in the operating
theatre on the sampling day, and the presence and use of the
UVS system and environmental and personal devices to
prevent FA exposure and health risks.
Urinary cotinine
Urinary cotinine was measured aiming to consider the poss-
ible role played by tobacco smoke in the onset of an oxidative
stress status. An aliquot of fresh urine was collected in the
morning approximately at the same time from each of the vol-
unteers, and stored at −80 °C prior to analysis, performed
within 20 working days. The enzyme immunoassay for cotinine
is based on the competition between the cotinine in the urine
sample and the cotinine–alkaline phosphatase conjugate: the
samples containing cotinine and the cotinine–alkaline phos-
phatase conjugate compete for binding to a limited number of
antibody sites. The bound enzymatic activity was measured by
the addition of a chromogenic substrate. Therefore, the inten-
sity of the color developed is inversely proportional to the con-
centration of cotinine in the sample. The concentration is
calculated on the basis of a standard curve. The declared limit
of detection is 1 ng ml−1.
Urinary isoprostane
15-F2t-IsoP in urine was quantified by means of the ELISA
technique performed with a specific microplate kit, according
to the manufacturer’s instructions, (Oxford, MI, USA). 15-F2t
IsoP in urine was measured by the ELISA technique performed
with a specific microplate kit (Oxford, MI, USA), according to
the manufacturer’s instructions. 15-F2t-IsoP in the samples or
standards competed with 15-F2t-IsoP conjugated to horse-
radish peroxidase (HRP) for binding to a polyclonal antibody
specific for 15-F2t-IsoP coated on the microplate. The HRP
activity resulted in color development when the substrate was
added, with the intensity inversely proportional to the amount
of unconjugated 15-F2t-IsoP in the samples or standards. The
declared limit of detection is 0.2 ng ml−1. A dilution of 1 : 4
was adopted to achieve better accuracy in the competitive
ELISA method. Because of the high percentage of 15-F2t IsoP
excreted in human urine conjugated to glucuronic acid (over
50%), a preliminary incubation with β-glucuronidase for 2 h at
37 °C was performed, in order to detect the entire quantity of
15-F2t IsoP present in each urine sample.
Urinary malondialdehyde
A TBARS Assay kit (Abnova), according to the manufacturer’s
instructions, was used to measure MDA in urine. An aliquot of
fresh urine was collected and stored at −80 °C prior to analysis
which was performed within 20 days. Urine does not require
any special treatments before analysis. The principle of this
method is based on the reaction of a chromogenic reagent,
2-thiobarbituric acid, with MDA at 25 °C. One molecule of
MDA reacts with 2 molecules of 2-thiobarbituric acid with a
Knoevenagel-type condensation to yield a chromophore with
the absorbance maximum at 532 nm.
Creatinine quantification
In order to normalize the excretion rate of cotinine and 15-F2t-
IsoP an aliquot of fresh urine was used to quantify the concen-
tration of creatinine (CREA) by the kinetic Jaffé procedure.
Statistical analysis
Data were analyzed using the STATA® vs. 13.0 statistical
package (StataCorp, Texas, USA). Appropriate linear transform-
ations were applied on data whenever suggested by distribu-
tional diagnostic plots (symmetry plot, quantile plot) and
descriptive statistic inspection (looking at variance stability
among categories). A log-transformation was performed to
find the power transformation that stabilizes the variance and
normalizes the distribution. To compare the values among the
resulting groups, a median test (non-parametric tests on the
equality of medians) was applied, checking the null hypothesis
Paper Toxicology Research
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that the K samples were drawn from populations with the
same median.
Multiple Linear Regression (MLR) analysis with a robust
standard error estimate was used to analyze the relationship
between log transformed personal air-FA (µg m−3) as a depen-
dent variable and the use of UVS and the type of container of
FA (prefilled or large container) as predictive variables and the
relationship of log transformed 15-F2t- and MDA with the per-
sonal air-FA. The models were adjusted for cotinine, and age.
For all tests, a p value of ≤0.05 (two-tailed) was considered sig-
nificant. All the variables proving a significativity ≥5% were
excluded.
Results
The 94 subjects, on the basis of the results of the question-
naire, were divided into 2 groups. The first group declared that
they had worked on the day of sampling in operating theatres
equipped with the UVS device, the second group stated that
they had worked in operating theatres without such a device.
In both types of theatres small biopsies (core or incisional)
were immersed by nurses in vials pre-filled with FA
(50–100 ml) and sent to the pathology laboratory. By studying
the results of the questionnaires we observed that the nurses
from the first type of surgical theatres (UVS-equipped) were
occasionally also committed to the management of liquid FA,
for filling up containers for specimens/organs >30 cm in size,
but most specimens (over 95%) were processed by UVS.
Table 1 describes the numerousness of groups of subjects
who used FA on the sampling day according to their smoking
habit. In the lower part of Table 1, the subjects were sub-
grouped according to the availability of UVS in the operating
theatres and, in both cases, also according to the epidemiolo-
gical characteristics and smoking habits.
Table 2 describes the personal air-FA concentrations
(μg m−3), which came out to be higher in the 64 subjects who
used FA on the sampling day (p = 0.032) and who related the
use of the UVS technique (p = 0.040) and FA (liquid or pre-
filled). The results indicate a significant difference related to
the adoption of the UVS system when the FA was not used (p =
0.002) but obviously even more so when the FA was used in the
liquid form (p = 0.001) and prefilled vials were not used. Fur-
thermore, workers who use liquid FA without the UVS tech-
nique show an overall exposure to FA more than three times
higher when compared to those who do not use this
procedure.
For further analysis, the FA concentrations were log-trans-
formed to normalize the distribution and improve the homo-
scedasticity. Thus, the robust regression shows on the one
hand the concentration of air-FA, when adjusted by UVS use,
to be directly proportional to the amount of FA used (liquid >
prefilled) and, on the other hand a lower level of air-FA when
the UVS technique is adopted, with a significant additional
role in the intensity of exposure to air-FA for both the use of
FA and the non-adoption of UVS technique (Table 3). Further-
more, given the significant interaction mentioned before, the
effect of UVS is higher in subjects exposed to liquid FA than in
Table 1 Number of subjects according to the use of FA and subject characteristics (means and standard deviations for variables in interval scales
and frequencies absolute and % for categorical variables ) subgrouped by vacuum presence
FA total (number) Subjects not using FA during the sampling day 64
Subjects using FA during the sampling day 30 FA prefilled 12
FA liquid 18
Smoking habits (number) Nonsmokers 51
Passive smokers 20
Active smokers 23
Yes UVS No UVS p
Total number 38 56 —
Means ± sd
Height (number) 163.1 ± 5.1 162.8 ± 6.1 NS
Weight (number) 61.9 ± 9.9 66.6 ± 16.4 NS
BMI 23.3 ± 3.7 25.1± 6.0 NS
Age (years) 45 ± 8.6 46.2 ± 7.6 NS
Absolute (%) frequencies
Smoking habits Nonsmokers 25 (46%) Nonsmokers 26 (66%) NS
Passive smokers 6 (25%) Passive smokers 14 (16%)
Active smokers 7 (29%) Active smokers 16 (18%)
FA (number) Subjects using FA 15 Subjects using FA 15 —
Prefilled 5 Prefilled 7 —
Liquid 10 Liquid 8
Subjects not using FAa 23 Subjects not using FAa 41 —
Statistical significativity estimated with nonparametric statistical tests for two independent samples. NS = not significant. aOn the day of
sampling.
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those exposed to prefilled FA (coef. log −0.51 vs. −0.15).
Overall, results of the linear regression of FA shown in Fig. 1,
underline that nurses who use the UVS system in the operating
rooms are exposed to levels of FA 75% lower than those who
do not use this system. Furthermore, as can be seen on the left
side of the figure the adoption of UVS allows halving of the
level of air-FA in the surgical theatre even on days when FA was
not used (no FA).
In the upper part of Table 4, it is seen that nurses who use
FA show concentrations of 15-F2t-IsoP significantly higher as
compared to those who are not users of FA (p < 0.001). The
concentrations of 15-F2t-IsoP show differences when the sub-
jects are sub-grouped according to the UVS procedure adopted.
Overall, 15-F2t-IsoP is higher in the absence of the UVS system
(p = 0.027) and, in particular, in those workers who use FA in
the operating theatre without UVS (p = 0.029). Besides, 15-F2t-
IsoP levels are two times higher in subjects who used liquid FA
in the absence of the UVS system (p = 0.012). In the middle
part of Table 4 the concentrations of MDA are reported. The
concentrations are significantly higher in subjects who use
liquid FA and are not provided with UVS (p = 0.012). Addition-
ally, in the lower part of Table 4 the ability of cotinine to effec-
tively quantify the intensity of exposure to tobacco smoke is
confirmed in the present subjects, since a significantly higher
level was observed in smokers (p = 0.035) but this factor did
not mask the use of different amounts of FA.
To deepen the positive relationship between FA exposure
and the synthesis of oxidative stress biomarkers, a multiple
robust regression was calculated considering 15-F2t-IsoP as the
dependent variable, MDA as a covariate, log-FA, UVS, urinary
cotinine, age of subjects, and BMI as independent variables
and confounding factors (Table 5). After adjustment for UVS,
cotinine, and age, findings show a positive and significant
relationship between air-FA and oxidative stress biomarkers.
Discussion
Since its introduction as a histological fixative back in the 19th
century,33 4% formaldehyde solution in water called formalin
has been adopted as the fixative of choice in histopathology.
Besides its superior properties in guaranteeing structural pres-
ervation, FA fixation allows an immunohistochemical and
genetic definition of pathological lesions and this multi-
Table 2 Personal air-FA (µg m−3) in the whole population (A), quantified according to the availability of UVS in the surgical theatres (B), the use of
FA on the day of sampling (C), and the robust regression between air-FA and use of UVS subgrouped by the type of container of FA (prefilled or
large container). C.I. = confidence interval
FA (µg m−3)
Means ± sd Nonparametric test
A Personal air-FA in the population n = 94) 20.7 ± 23.3
Subjects using FA (n = 64) 33.7 ± 37.9 p = 0.032
Subjects not using FA (n = 30) 14.6 ± 4.6
UVS NO UVS Nonparametric test UVS vs. NO UVS
B
All the subjects 15.5 ± 7.4 All the subjects 24.2 ± 29.1 p = 0.040
Subjects not using FA 12.1 ± 2.6 Subjects not using FA 16.0 ± 4.9 p = 0.002
C Subjects using FA 20.7 ± 9.3 Subjects using FA 46.7 ± 50.3 p = 0.001
FA prefilled 18.4 ± 5.4 FA prefilled 25.6 ± 5.5 N.S.
FA liquid 20.9 ± 9.7 FA liquid 65.0 ± 64.0 p = 0.001
Table 3 The robust regression between air-FA and use of UVS end
interaction (between UVS use and the type of container of FA (prefilled
or large container)). C.I. = confidence interval within square brackets.
NB exponentiation of coefficients expresses the proportion of variation
by each group
log FA
Regression
coefficient B
Exponential
exp (B)
Std.
error p
Prefilled
(adj. by UVS)
0.49 [0.32–0.67] 1.65 0.08 0.000
Liquid (adj.
by UVS)
1.06 [0.83–1.29] 2.90 0.11 0.000
Personal air-
FA with UVS
−0.26 [0.38––0.12] 0.77 0.06 0.000
Prefilled −0.15 [−0.60–0.30] 0.86 0.22 N.S.
liquid −0.51 [−0.84––0.18] 0.60 0.16 0.003
Fig. 1 Linear regression of FA levels adjusted by cotinine and BMI sub-
grouped by UVS and the use of FA.
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faceted characterization carries paramount importance in
planning therapies.34 This implies that health authorities
would object to the fact that dismissal of the use of FA would
cause major harm to the quality of diagnosis for patients.
FA is known to be toxic and is classified as a category 1B/2
carcinogen and a significant association was demonstrated
between formalin-fixation procedures and the generation of
oxidatively damaged DNA testified also by the formation of the
molecular adduct M1dG.27 This would justify its banning, as
recently proposed by EU authorities. FA can induce increased
levels of oxidative stress and enhanced formation of ROS by
different ways, including the activation of oxidases and the
inhibition of scavenger systems. For instance, FA is a substrate
for the action of the cytochrome P-450 monooxygenase system
II E1 isozyme and can be oxidized by peroxidase, aldehyde
oxidase, and xanthine oxidase with subsequent ROS for-
mation. However, given that to date a reagent able to guarantee
the same performance in histopathology is not available, a
reasonable policy is to reduce the risk, by creating working
conditions in which the exposure of the personnel involved is
limited to an acceptable minimum.
The present study shows that the adoption of the UVS pro-
cedure for the transfer of surgical specimens to the pathology
labs results in a sharp decline in the exposure of nurses to FA.
In fact, we give evidence of the reduction of oxidative stress in
nurses adopting the UVS technique as an alternative to the use
of FA in operating theatres. These data add to the already
acquired experience on the advantages offered by the UVS pro-
cedure, in terms of improved tissue preservation for diagnosis
and research, and appreciation of the operational feasibility of
the process, by the nursing staff.29
The present study indicates that the major source of
exposure to FA is not its use in pre-filled vials for fixing small
biopsies, since in fact this procedure was carried out in both
types of surgical theatres, while the bulk of exposure is related
to the habit of pouring liquid FA (3–5 litres at a time) in large
containers. In fact, the volunteers enrolled for this study who
Table 4 15-F2t-IsoP, MDA and cotinine subgrouped according to the UVS availability, use of FA and smoking exposure (CREA = creatinine). The
models were adjusted by age, gender, BMI and cotinine
15-F2t-IsoP (ng mg−1 CREA)
Subjects using FA 12.9 ± 6.9 p = 0.001
Subjects not using FA 3.8 ± 3.1
UVS NO UVS
6.3 ± 4.5 7.0 ± 7.3 p = 0.027
Subjects using FA 10.1 ± 4.3 Subjects using FA 15.8 ± 8.0 p = 0.029
Subjects not using FA 3.7 ± 3.3 Subjects not using FA 3.9 ± 2.7 N.S.
FA prefilled 6.4 ± 2.2 FA prefilled 10.9 ± 6.2 N.S.
FA liquid 11.9 ± 3.9 FA liquid 20.1 ± 7.1 0.012
MDA (µM)
Subjects using FA 1.9 ± 0.7 N.S.
Subjects not using FA 1.2 ± 0.6
UVS NO UVS
1.3 ± 0.8 1.5 ± 0.6 N.S.
Subjects using FA 1.7 ± 0.5 Subjects using FA 2.1 ± 0.9 N.S.
Subjects not using FA 1.1 ± 0.5 Subjects not using FA 1.3 ± 0.6 N.S.
FA prefilled 1.4 ± 0.3 FA prefilled 1.5 ± 0.2 N.S.
FA liquid 1.8 ± 0.4 FA liquid 2.6 ± 0.9 p = 0.012
Cotinine (ng mg−1 CREA)
The whole population 32.8 ± 59.5
Nonsmokers 3.1 ± 2.0 p = 0.035
Passive smokers 6.2 ± 10.7
Active smokers 109.0 ± 68.2
Subjects using FA 28.9 ± 61.8 N.S.
Subjects not using FA 34.1 ± 58.8
Table 5 Robust regression between log-15-F2t-IsoP and MDA as
dependent variables and log-FA as an independent variable. UVS, coti-
nine, and age effect were not significant at the 5% level. C.I. = confi-
dence interval
Independent
Regression
coefficient B
Exponential
exp (B) p
log[MDA] 0.77 [0.38–1.17] 2.18 0.002
Constant −2.04 [−3.04––1.05] 0.13
log[15-F2t-IsoP] 1.02 [0.66–1.38] 2.78 0.001
Constant −1.45 [−2.64––2.47] 0.23
NB exponentiation of coefficients expresses the proportion of variation
for the unit of variation of log(FA).
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used FA in the liquid form showed a significantly higher
exposure to FA than those who have not used it. Moreover, in
preventive terms, the use of FA prefilled and, even more the
use of the technique UVS, shows a significant reduction of the
exposure to air-FA. Furthermore, the use of the UVS technique
fosters a lower level of air-FA as compared to that of theatres
not equipped with the UVS apparatus, thus demonstrating a
long-term “environmental efficiency” of UVS.
The more macroscopic effect of the UVS technique is
anyway observable when FA is used in the liquid form, since
its breathable concentration is, in surgical theatres not
equipped with UVS, 3 times higher. The robust regression
(Table 3) confirms a significant and independent interaction
of air-FA exposure and the UVS technique, underlining that
the human intake of FA increases both as a result of the use of
a higher amount of FA and by the unavailability of the UVS
technique. The linear regression of air-FA sub-grouped accord-
ing to the UVS use and adjusted by cotinine and BMI high-
lighted in Fig. 1, allowed us to observe a greater effectiveness
(−75%) of the UVS technique on the air-FA levels. In particular,
these findings were evident among those who use the FA
liquid than FA in prefilled vials (Table 3).
Analysis of biological oxidative stress biomarkers confirms
a direct responsibility of air FA on the onset of oxidative stress.
15-F2t-IsoP is synthesized in a significantly higher quantity
when FA is used, in theatres where the UVS technique is not
available, and when, without UVS, FA is used in the liquid
form. MDA seems to respond in a less sensitive way, proving to
be significantly higher only when nurses are exposed to liquid
FA that is to say to FA at higher concentrations. This aspect
may depend on the biochemical characteristics of MDA, sensi-
tive to FA in a direct way, but most easily degradable, especially
in the case of healthy subjects exposed chronically but not in a
continuous way. Thus, in future studies we believe that a
measurement of 15-F2t-IsoP will be largely sufficient to quan-
tify the extent of oxidative stress in the populations occupa-
tionally or environmentally exposed to formaldehyde.
In this study, cotinine was confirmed as a very sensitive and
specific internal dose marker of smoking habits, and we were
able to exclude the role of this confounding factor among the
subpopulations studied. In fact, cotinine is a metabolite of nic-
otine and nicotine is a chemical present only in the tobacco
leaves. Finally, a definitive evidence of the direct relationship
between exposure to air-FA and increase in oxidative stress is
provided by the robust multiple regression that describes this
relationship for 15-F2t-IsoP and MDA (Table 5), after adjustment
for the use of the UVS technique, exposure to smoking and age.
The principal finding of this study is to underline the pre-
ventive role of the adoption of the UVS system, which is bound
to eliminate exposure to formalin in the operating rooms.
Thus, the adoption of the UVS procedure appears to offer
both, environmental and technical advantages. In fact, on the
one hand pathologists declare themselves largely satisfied by
the histological characteristics of the tissues preserved under
vacuum at +4 °C and, on the other hand, our results highlight
the drastic reduction in workers’ exposure to airborne FA, both
in environmental and biological terms. This indicates that the
adoption of the UVS procedure lead to the elimination of FA in
operating rooms and a significant reduction of FA in pathology
departments receiving the tissues.
Our findings can be useful to characterize the risk in terms
of imbalance of the redox status, experienced for subjects
working in the operating theatre engaged or not in the UVS
procedure. However, the predictive role of the biomarkers of
early biological effects is quite limited to assess individual
risk. This is because the complex processes that lead from the
exposure to formalin to diseases are affected by many factors,
many of which are still unknown or whose real impact is not
estimable (e.g., individual genetic profile, age, life and working
style, health status, etc.).
In conclusion, given that the complete elimination of FA
from the health care system can hardly be adopted since it
would impact the quality of diagnosis for patients, the
reduction of exposure seems a reasonable compromise. The
present study demonstrates that preventive measures can be
effective and the behaviour of the oxidative stress biomarkers
highlights the feasibility of this approach. The crucial preven-
tive role of the adoption of the UVS technique in operating
theatres27,35 is demonstrated here.
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